Galmed Pharma (GLMD) Tops Q1 EPS by 10c

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.15), $0.10 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
• Core & Main, Inc (CNM) Tops Q2 EPS by 18c, Beats on Revenue; Reaffirms Guidance
• BorgWarner upgraded to buy at UBS as data-center power opportunity gains traction